Frigate Ventures LP 13D and 13G filings for Spero Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:37 pm Sale |
2024-09-30 | 13G | Spero Therapeutics, Inc. SPRO |
Frigate Ventures LP | 3,750,450 6.900% |
-547,149 (-12.73%) |
Filing |
| 2024-02-14 4:25 pm Purchase |
2023-12-31 | 13G | Spero Therapeutics, Inc. SPRO |
Frigate Ventures LP | 4,297,599 8.100% |
4,297,599 (New Position) |
Filing |